✳flâneur — a map of the web's best reading
How unfair is the coin?
ankitg.me · 3,832 words · saved by 1 readers
Lessons on Building an AI x Bio Startup
How unfair is the coin? Ankit Gupta Blog Contact / Github / How unfair is the coin? Monday. January 06, 2025 I’m reviving my blog after some time away — it’s been an eventful 12 months. In February 2024, Reverie Labs, the startup I co-founded in 2017, was acquired by Ginkgo Bioworks. I’m now on leave from Ginkgo and I’ve joined Y Combinator as a Visiting Partner, giving me the chance to work with the next generation of companies. Especially in this new role, I’ve been thinking a bit about what worked, what didn’t work, and what lessons I can take forward. We had quite the journey – 6+ years of
Explore this link on the map →related reading
- Rebuild Biotech for the AI Era | Benchlingbenchling.com
- Liquidity in Drug Discovery – Bharath Ramsundar – Entrepreneur and Scientistrbharath.github.io
- Tech vs Biotech - Celine Haliouacelinehh.com
- Requests for Startups | Y Combinatorycombinator.com
- What will it take for AI to change drug discovery?writingruxandrabio.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- On AI Infrastructure in Biology - by Elliot Hershbergcenturyofbio.com
- Curious cases of financial engineering in biotechowlposting.com
- Why is progress in biology so slow?sam-rodriques.com
- Anatomy of a Biotech Business Development Deal | Andreessen Horowitza16z.com
- Some questions about biotech that I find interesting | Alex’s blogatelfo.github.io
- Convoke Raises $8.6M to Build the AI Operating System for Biopharma - Convoke | Biopharma's new workspaceconvoke.bio